Previous 10 | Next 10 |
CLEVELAND, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On October 31, 2023, th...
2023-09-26 11:27:12 ET More on Abeona Therapeutics Seeking Alpha’s Quant Rating on Abeona Therapeutics Historical earnings data for Abeona Therapeutics Financial information for Abeona Therapeutics Abeona Therapeutics Inc. (ABEO) Q2 2023 Earnings Call ...
CLEVELAND, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the Company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of EB-101, its investigational autologous, engineered cell therapy,...
2023-09-12 12:48:04 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in biotech stock can provide investors with immense rewards but also substantial risks. The key is finding the right balance. With diligent research, it’s possible to...
CLEVELAND, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Madhav Vasanthavada, Ph.D., M.B.A. to the role of Chief Commercial Officer (CCO) and Head of Business Development (BD), effective immediately. In this capacity, in addition to ...
2023-08-30 08:35:22 ET More on Abeona Abeona Therapeutics Inc. ( ABEO ) Q2 2023 Earnings Call Transcript Abeona spikes after regulatory update on lead program Abeona expects BLA filing for cell therapy in Q3 as FDA requests more data Abeona stock rises on...
CLEVELAND, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the Company’s intention to proceed with the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for EB-101, its investigational autologous, en...
2023-08-18 13:06:58 ET Gainers: Neptune Wellness Solutions ( NEPT ) +77% . TOP Financial Group ( TOP ) +29% . Hitek Global ( HKIT ) +22% . Agenus ( AGEN ) +19% . ReTo Eco-Solutions ( RETO ) +19% . BK Technol...
2023-08-12 13:42:09 ET Abeona Therapeutics Inc. (ABEO) Q2 2023 Results Conference Call August 08, 2023 08:30 AM ET Company Participants Greg Gin - Vice President of Investor Relations and Corporate Communications Vish Seshadri - Chief Executive Officer Joe Vazzan...
2023-08-08 07:52:20 ET Abeona Therapeutics press release ( NASDAQ: ABEO ): Q2 GAAP EPS of -$0.92 misses by $0.25 . Revenue of $3.5M (+250.0% Y/Y). For further details see: Abeona Therapeutics GAAP EPS of -$0.92 misses by $0.25, revenue of $3.5M
News, Short Squeeze, Breakout and More Instantly...
Abeona Therapeutics Inc. Company Name:
ABEO Stock Symbol:
NASDAQ Market:
Abeona Therapeutics Inc. Website:
BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, extending expected cash runway into 2026 CLEVELAND, May 15, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
CLEVELAND, May 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) (“Abeona” or the “Company”) today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock and, in lieu of common stock, pre-funded warrants to purchas...